🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 20 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 04/01/2018 | 149,76 | 150,81 | 148,21 | 149,83 | -0,17% | 1,74% | 456.000 |
| 03/01/2018 | 151,10 | 152,55 | 149,93 | 150,09 | -1,22% | 1,73% | 259.500 |
| 02/01/2018 | 148,64 | 152,35 | 148,13 | 151,94 | +2,70% | 2,84% | 441.300 |
| 29/12/2017 | 150,09 | 150,86 | 147,64 | 147,95 | -0,86% | 2,15% | 228.600 |
| 28/12/2017 | 151,05 | 151,56 | 148,19 | 149,24 | -1,35% | 2,23% | 296.800 |
| 27/12/2017 | 150,03 | 152,47 | 146,15 | 151,28 | +0,83% | 4,21% | 626.800 |
| 26/12/2017 | 137,90 | 150,66 | 137,90 | 150,03 | +9,31% | 9,25% | 673.500 |
| 22/12/2017 | 135,28 | 137,55 | 134,48 | 137,25 | +1,71% | 2,27% | 308.800 |
| 21/12/2017 | 135,52 | 136,19 | 134,57 | 134,94 | -0,68% | 1,20% | 257.600 |
| 20/12/2017 | 136,73 | 137,54 | 135,33 | 135,86 | +0,25% | 1,62% | 393.400 |
| 19/12/2017 | 136,02 | 137,01 | 134,79 | 135,52 | -0,51% | 1,63% | 521.300 |
| 18/12/2017 | 138,40 | 138,58 | 135,92 | 136,21 | -0,87% | 1,92% | 326.400 |
| 15/12/2017 | 136,28 | 138,36 | 135,22 | 137,41 | +1,20% | 2,30% | 911.200 |
| 14/12/2017 | 135,96 | 136,69 | 134,34 | 135,78 | -0,37% | 1,73% | 321.800 |
| 13/12/2017 | 134,74 | 137,31 | 134,67 | 136,29 | +0,79% | 1,96% | 460.400 |
| 12/12/2017 | 135,23 | 136,14 | 134,35 | 135,22 | -0,29% | 1,32% | 375.100 |
| 11/12/2017 | 136,30 | 136,64 | 134,63 | 135,61 | -0,44% | 1,47% | 293.000 |
| 08/12/2017 | 137,45 | 138,26 | 135,49 | 136,21 | -0,63% | 2,02% | 279.400 |
| 07/12/2017 | 134,72 | 137,43 | 132,43 | 137,07 | +2,11% | 3,71% | 440.100 |
| 06/12/2017 | 134,67 | 134,67 | 133,03 | 134,24 | +0,05% | 1,22% | 252.200 |
| 05/12/2017 | 135,22 | 135,46 | 133,13 | 134,17 | +0,11% | 1,72% | 294.400 |
| 04/12/2017 | 133,22 | 136,72 | 132,70 | 134,02 | +0,53% | 3,02% | 626.300 |
| 01/12/2017 | 130,42 | 133,46 | 127,97 | 133,32 | +2,56% | 4,21% | 342.200 |
| 30/11/2017 | 129,00 | 130,59 | 126,93 | 129,99 | +0,67% | 2,84% | 550.300 |
| 29/11/2017 | 125,13 | 129,85 | 124,43 | 129,12 | +3,67% | 4,33% | 331.300 |
| 28/11/2017 | 121,18 | 127,00 | 120,33 | 124,55 | +3,78% | 5,50% | 706.500 |
| 27/11/2017 | 125,32 | 125,82 | 119,92 | 120,01 | -4,00% | 4,71% | 319.300 |
| 24/11/2017 | 125,68 | 126,58 | 123,24 | 125,01 | -0,32% | 2,66% | 218.000 |
| 22/11/2017 | 125,24 | 126,64 | 124,78 | 125,41 | +0,00% | 1,49% | 259.200 |
| 21/11/2017 | 126,50 | 126,75 | 124,09 | 125,41 | -0,63% | 2,10% | 436.800 |